Cell Impact AB (publ) (STO:CI)
Sweden · Delayed Price · Currency is SEK 0.0568
+0.0016 (2.90%)
Aug 14, 2026, 5:29 PM CET
Cell Impact AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5.12 | 5.57 | 37.33 | 47.26 | 76.81 | 71.35 |
Other Revenue | 0.17 | 0.12 | 0.6 | 0.4 | 0.9 | 10.45 |
| 5.29 | 5.69 | 37.92 | 47.66 | 77.71 | 81.8 | |
Revenue Growth | -55.58% | -85.01% | -20.44% | -38.67% | -5.00% | 179.09% |
Cost of Revenue | 5.08 | 10.66 | 31.91 | 21.81 | 39.87 | 46.92 |
Gross Profit | 0.21 | -4.97 | 6.01 | 25.85 | 37.84 | 34.88 |
Selling, General & Admin | 46.52 | 46.96 | 62.27 | 120.04 | 124 | 102.68 |
Other Operating Expenses | 3.37 | 3.1 | 11.5 | 1.64 | 0.92 | 0.05 |
Operating Expenses | 121.27 | 122.94 | 105.03 | 145.34 | 141.3 | 112.92 |
Operating Income | -121.06 | -127.91 | -99.02 | -119.49 | -103.47 | -78.04 |
Interest Expense | -4.6 | -4.41 | -2.56 | -3.05 | -1.54 | -1.69 |
Interest & Investment Income | 0.21 | 0.21 | 1.47 | 1.18 | 0.86 | - |
Currency Exchange Gain (Loss) | -0.23 | -0.23 | -0.23 | - | - | - |
Other Non Operating Income (Expenses) | 0.37 | 0.37 | - | -0 | -0 | -0 |
Pretax Income | -125.31 | -131.98 | -100.35 | -121.36 | -104.15 | -79.73 |
Income Tax Expense | 0.04 | 0.01 | 0.09 | 0.04 | 0.07 | 0.12 |
Net Income | -125.35 | -131.98 | -100.43 | -121.4 | -104.22 | -79.85 |
Net Income to Common | -125.35 | -131.98 | -100.43 | -121.4 | -104.22 | -79.85 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 31 | 169 | 62 | 11 | 8 | 6 |
Shares Outstanding (Diluted) | 31 | 169 | 62 | 11 | 8 | 6 |
Shares Change | -91.90% | 173.52% | 463.84% | 44.78% | 27.89% | 17.66% |
EPS (Basic) | -4.07 | -0.78 | -1.62 | -11.07 | -13.76 | -13.49 |
EPS (Diluted) | -4.07 | -0.78 | -1.62 | -11.07 | -13.76 | -13.49 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -36.31 | -47.29 | -74.64 | -156.29 | -168.37 | -139.05 |
Free Cash Flow Per Share | -1.18 | -0.28 | -1.21 | -14.26 | -22.23 | -23.48 |
Gross Margin | 4.01% | -87.41% | 15.86% | 54.24% | 48.69% | 42.64% |
Operating Margin | -2288.45% | -2249.63% | -261.12% | -250.70% | -133.14% | -95.40% |
Profit Margin | -2369.51% | -2321.21% | -264.84% | -254.71% | -134.11% | -97.62% |
Free Cash Flow Margin | -686.35% | -831.69% | -196.82% | -327.92% | -216.66% | -169.99% |
EBITDA | -100.24 | -105.59 | -80.16 | -106.32 | -92.29 | -72.3 |
EBITDA Margin | - | - | -211.38% | -223.07% | -118.76% | -88.39% |
D&A For EBITDA | 20.82 | 22.32 | 18.86 | 13.17 | 11.18 | 5.74 |
EBIT | -121.06 | -127.91 | -99.02 | -119.49 | -103.47 | -78.04 |
EBIT Margin | - | - | -261.12% | -250.70% | -133.14% | -95.40% |
Revenue as Reported | 3.79 | 2.07 | 26.85 | 48.58 | 93.03 | 81.8 |